203 related articles for article (PubMed ID: 330775)
1. Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.
McCabe WR; Bruins SC; Craven DE; Johns M
J Infect Dis; 1977 Aug; 136 Suppl():S161-6. PubMed ID: 330775
[TBL] [Abstract][Full Text] [Related]
2. Potential use of shared antigens for immunization against gram-negative bacillary infections.
McCabe WR; DeMaria A; Johns M
Prog Clin Biol Res; 1980; 47():107-17. PubMed ID: 6163155
[TBL] [Abstract][Full Text] [Related]
3. Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae.
Young LS; Stevens P
J Infect Dis; 1977 Aug; 136 Suppl():S174-80. PubMed ID: 19538
[TBL] [Abstract][Full Text] [Related]
4. Functional role of antibody against "core" glycolipid of Enterobacteriaceae.
Young LS; Stevens P; Ingram J
J Clin Invest; 1975 Oct; 56(4):850-61. PubMed ID: 1099119
[TBL] [Abstract][Full Text] [Related]
5. Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant.
Bruins SC; Stumacher R; Johns MA; McCabe WR
Infect Immun; 1977 Jul; 17(1):16-20. PubMed ID: 407161
[TBL] [Abstract][Full Text] [Related]
6. Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants.
Johns MA; Bruins SC; McCabe WR
Infect Immun; 1977 Jul; 17(1):9-15. PubMed ID: 69613
[TBL] [Abstract][Full Text] [Related]
7. Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutant.
McCabe WR; DeMaria A; Berberich H; Johns MA
J Infect Dis; 1988 Aug; 158(2):291-300. PubMed ID: 3042871
[TBL] [Abstract][Full Text] [Related]
8. Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects.
DeMaria A; Johns MA; Berberich H; McCabe WR
J Infect Dis; 1988 Aug; 158(2):301-11. PubMed ID: 3042872
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
Nys M; Cloes JM; Demonty J; Joassin L
J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
[TBL] [Abstract][Full Text] [Related]
10. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
McCabe WR
J Immunol; 1972 Mar; 108(3):601-10. PubMed ID: 4622185
[No Abstract] [Full Text] [Related]
11. Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections.
Ng AK; Chen CL; Chang CM; Nowotny A
J Gen Microbiol; 1976 May; 94(1):107-16. PubMed ID: 778329
[TBL] [Abstract][Full Text] [Related]
12. Effect of active and passive immunizations with lipid A and salmonella minnesota Re 595 on gram-negative infections in mice.
Hodgin LA; Drews J
Infection; 1976; 4(2):5-10. PubMed ID: 789248
[TBL] [Abstract][Full Text] [Related]
13. Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin.
Johns M; Skehill A; McCabe WR
J Infect Dis; 1983 Jan; 147(1):57-67. PubMed ID: 6185599
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
Siber GR; Kania SA; Warren HS
J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
[TBL] [Abstract][Full Text] [Related]
15. [Immunostimulating activity of combined antigens of Klebsiella pneumoniae, Staphylococcus, Proteus and Escherichia coli and separate components in cross infection].
Egorova NB; Kreĭnin LS; Efremova VN; Kaverina KG; Mansurova NL
Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):70-4. PubMed ID: 3907218
[TBL] [Abstract][Full Text] [Related]
16. Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality.
Greisman SE; Johnston CA
J Infect Dis; 1988 Jan; 157(1):54-64. PubMed ID: 2447200
[TBL] [Abstract][Full Text] [Related]
17. Common enterobacterial antigen. II. Effect of immunization on challenge with heterologous bacilli.
McCabe WR; Greely A
Infect Immun; 1973 Mar; 7(3):386-92. PubMed ID: 4576679
[TBL] [Abstract][Full Text] [Related]
18. Type-specific and cross-reactive antibodies in gram-negative bacteremia.
McCabe WR; Kreger BE; Johns M
N Engl J Med; 1972 Aug; 287(6):261-7. PubMed ID: 5038951
[No Abstract] [Full Text] [Related]
19. Specific and Nonspecific immunity to Serratia marcescens infection.
Simberkoff MS; Moldover NH; Rahal JJ
J Infect Dis; 1976 Oct; 134(4):348-53. PubMed ID: 789788
[TBL] [Abstract][Full Text] [Related]
20. [Proteus peritonitis-bacteremia in mice--a model for studying postvaccinal Proteus immunity].
Zaĭtsev EV; Levina LA
Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):74-8. PubMed ID: 2251896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
